Eptinezumab for migraine prevention in patients 50 years or older. Martin V, Tassorelli C, Ettrup A, Hirman J, et al. Acta Neurol Scand 2022 Feb 26. doi: 10.1111/ane.13603.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Martin V, Tassorelli C, Ettrup A, Hirman J, et al. Eptinezumab for migraine prevention in patients 50 years or older. Acta Neurol Scand 2022 Feb 26. doi: 10.1111/ane.13603.
PMID: 35218203